5th Asian Conference *New Videos * Out

[partimefriend]

May 28, 2016 - May 29, 2016

Session 3: HBV - Future Treatment Options

Dr. Bruce D Given, MD, Arrowhead Research Corporation, USA

Man-Fung Yuen RNAi therapeutics for chronic HBV - Clinical data







www.virology-education.com/wp-content/uploads/2015/06/5ACHA_Program_20160512.pdf

[qbeing1010]

When I look at this program, I am encouraged. It looks to me like we get a full hour, with three big speakers. A world leader in HBV will go first, to speak about new therapeutics (DPC & 520/1?) and targets, followed by ARWR's Dr. Givens to describe cHBV models in animals, and finished by a Chinese expert on HBV to discuss clinical results of RNAi therapeutics for cHBV. 1, 2, 3, POW!

[strategicinvestor22]

ALSO, the conference is sponsored by GSK, Gilead, and AbbVie. Like you said, the experts and Givens will spend about an hour discussing ARC520/521. The roster of speakers would indicate that ARWR is the only company invited to speak... all the rest are researchers, academia, and medical professionals. Last year, there were no companies invited to speak from what I can tell. Encouraging for sure!!

[partimefriend]

Hopefully we will get to see the presentations . 


 We are pleased to inform you that the presentations with the speakers’ permissions will be soon available online on Infections Diseases Online. The webcast of the presentations will also be published on this website shortly.

www.infectiousdiseasesonline.com






vimeo.com/user23521970

[partimefriend]

New videos


vimeo.com/user23521970